| Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label … CS Goodyear, A Patel, E Barnes, M Willicombe, S Siebert, TI de Silva, ... The Lancet Rheumatology 6 (6), e339-e351, 2024 | 1 | 2024 |
| Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign M Shawe-Taylor, D Greenwood, A Hobbs, G Dowgier, R Penn, ... The Lancet 403 (10432), 1133-1136, 2024 | 1 | 2024 |
| Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN. 1 G Dowgier, A Hobbs, D Greenwood, M Shawe-Taylor, ... bioRxiv, 2024.04. 17.589886, 2024 | | 2024 |
| SARS-CoV-2 mucosal neutralising immunity after vaccination EJ Carr, G Dowgier, D Greenwood, LS Herman, A Hobbs, M Ragno, ... The Lancet Infectious Diseases 24 (1), e4-e5, 2024 | 2 | 2024 |
| 33 Fourth dose bivalent mRNA vaccines containing BA. 1 significantly augment neutralising antibody titres against SARS-COV-2 Omicron sub-lineages XBB and BQ. 1.1 in healthy adults M Wu, E Carr, R Harvey, J Gahir, H Townsley, G Dowgier, A Hobbs, ... Clinical Infection in Practice 20, 100260, 2023 | | 2023 |
| Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study A Atti, F Insalata, EJ Carr, AD Otter, S Foulkes, MY Wu, MJ Cole, E Linley, ... Journal of Infection 87 (5), 420-427, 2023 | 4 | 2023 |
| CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study I Neale, M Ali, B Kronsteiner, S Longet, P Abraham, AS Deeks, A Brown, ... Mbio 14 (5), e01212-23, 2023 | 1 | 2023 |
| Commercial immunoglobulin products contain neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 spike protein V Upasani, K Townsend, MY Wu, EJ Carr, A Hobbs, G Dowgier, M Ragno, ... Clinical Infectious Diseases 77 (7), 950-960, 2023 | 17 | 2023 |
| Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London C Bailey, T Sanderson, H Townsley, J Goldman, JRM Black, G Young, ... The Lancet 402 (10395), 21-24, 2023 | 3 | 2023 |
| Neutralising immunity to omicron sublineages BQ. 1.1, XBB, and XBB. 1.5 in healthy adults is boosted by bivalent BA. 1-containing mRNA vaccination and previous Omicron infection EJ Carr, MY Wu, J Gahir, R Harvey, H Townsley, C Bailey, AS Fowler, ... The Lancet Infectious Diseases 23 (7), 781-784, 2023 | 10 | 2023 |
| Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults EJ Carr, H Townsley, MY Wu, KA Wilkinson, PS Hobson, D Levi, ... bioRxiv, 2023.05. 24.541920, 2023 | 1 | 2023 |
| Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer MY Wu, STC Shepherd, A Fendler, EJ Carr, L Au, R Harvey, G Dowgier, ... Cancer cell 41 (5), 821-823, 2023 | 4 | 2023 |
| CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study I Neale, M Ali, B Kronsteiner, S Longet, P Abraham, AS Deeks, A Brown, ... medRxiv, 2023.02. 16.23285748, 2023 | 2 | 2023 |
| Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults (preprint) EJ Carr, H Townsley, MY Wu, KA Wilkinson, PS Hobson, D Levi, ... | | 2023 |
| Examining the association of live virus neutralisation activity of capillary microsamples and risk of SARS-CoV-2 infections: a nested case control study within the Virus Watch … A Yavlinsky, V Nguyen, S Beale, E Wall, MY Wu, I Braithwaite, J Kovar, ... medRxiv, 2023.11. 28.23299156, 2023 | | 2023 |
| Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes G Tut, T Lancaster, M Krutikov, P Sylla, D Bone, E Spalkova, C Bentley, ... Nature Aging 3 (1), 93-104, 2023 | 13 | 2023 |
| WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed MY Wu, EJ Carr, R Harvey, HV Mears, S Kjaer, H Townsley, A Hobbs, ... The Lancet 400 (10369), 2193-2196, 2022 | 46 | 2022 |
| Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study A Atti, F Insalata, EJ Carr, AD Otter, J Castillo-Olivares, M Wu, R Harvey, ... Journal of Infection 85 (5), 545-556, 2022 | 24 | 2022 |
| Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, KA Wilkinson, ... Cell Reports Medicine 3 (10), 2022 | 22 | 2022 |
| SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies KW Ng, N Faulkner, K Finsterbusch, M Wu, R Harvey, S Hussain, M Greco, ... Science translational medicine 14 (655), eabn3715, 2022 | 74 | 2022 |
